Esperion to Participate in Upcoming Virtual Investor Conference
Get Alerts ESPR Hot Sheet
Join SI Premium – FREE
ANN ARBOR, Mich., Oct. 27, 2021 (GLOBE NEWSWIRE) -- Esperion (NASDAQ: ESPR) today announced that members of Esperion’s management team will participate in the upcoming Credit Suisse 30th Annual Healthcare Conference.
| Event: | Credit Suisse 30th Annual Healthcare Conference |
| Date: | Tuesday, November 9, 2021 |
| Format: | Fireside Chat and 1:1 Meetings |
| Time: | 4:20 p.m. ET |
Live audio webcasts of these events can be accessed on the investor relations section of the Esperion website at www.esperion.com/investors-media/events-presentations/. Replays of the webcasts will be archived on the Company's website for 90 days following the events.
Esperion Therapeutics
Esperion is The Lipid Management Company. Our goal is lipid management for everybody, that’s why we work hard to make our medicines easy to get, easy to take and easy to have. We discover, develop and commercialize innovative medicines and combinations to lower cholesterol, especially for patients whose needs aren’t being met by the status quo. Our entrepreneurial team of industry leaders is inclusive, passionate and resourceful. For more information, please visit www.esperion.com and follow us on Twitter at www.twitter.com/EsperionInc.
Investor Contact:Kaitlyn BroscoEsperion[email protected]
Source: Esperion Therapeutics, Inc.
Serious News for Serious Traders! Try StreetInsider.com Premium Free!
You May Also Be Interested In
- She Made it – the Youngest South African Woman to Swim the Channel
- Dogecoin and Floki Got Away While You Waited: APEING Could Be the Next 100x Meme Coin With Over 12,000+ Whitelist Members
- Humaans Expands Into US Payroll As It Accelerates US Growth
Create E-mail Alert Related Categories
Globe Newswire, Press ReleasesRelated Entities
Credit Suisse, TwitterSign up for StreetInsider Free!
Receive full access to all new and archived articles, unlimited portfolio tracking, e-mail alerts, custom newswires and RSS feeds - and more!



Tweet
Share